Question

Will tirzepatide be approved for the treatment of obesity by the FDA or EMA before 2025?

Resolved :Yes

8 comments8

Total Forecasters36

Community Prediction80%

Make a Prediction

community: 80%

Did this actually happen?Yes

Community Baseline Score

29.9

Community Peer Score

1.3

median 80.0%mean 80.5%

Authors:

casens

Opened:

Closes:

Resolves:

Eli Lilly and Company

Semaglutide

Pharmacology

Obesity

Food and Drug Administration

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

81%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

60%

Comments

? comments